首页> 外国专利> METHOD FOR PRODUCING A SUBUNIT VACCINE AGAINST THE CANINE PARVOVIRUS AND OTHER RELATED VIRUSES

METHOD FOR PRODUCING A SUBUNIT VACCINE AGAINST THE CANINE PARVOVIRUS AND OTHER RELATED VIRUSES

机译:生产针对犬细小病毒和其他相关病毒的亚单位疫苗的方法

摘要

The invention relates to a method for producing a subunit vaccine against canine parvovirus (CPV) and other related viruses (FPLV and MEV). The method is comprised of a first step to obtain a recombinant protein VP2 of CPV using the replication of a recombinant baculovirus, wherein the gene corresponding to the VP2 had been previously introduced in cells of a permissive host. The protein VP2 obtained in this invention has the capacity of forming empty chimeric capsides with high immunogenicity so that they can be formulated into vaccines for protecting animals against infection caused by CPV, FPLV and MEV. Additionnaly they may be chemically or genetically engineered in order to incorporate epitopes corresponding to other viral proteins and they may be used in the formulation of polyvalent vaccines. The recombinant baculovirus AcMNPV.pCPVEx17 expresses the protein VP2 of the virus CPV in conditions which enable it to form pseudo-viral capsides and has been deposited at the ECACC. Said vaccine finds application in the veterinary field.
机译:本发明涉及生产针对犬细小病毒(CPV)和其他相关病毒(FPLV和MEV)的亚单位疫苗的方法。该方法包括第一步,即使用重组杆状病毒的复制获得CPV的重组蛋白VP2,其中对应于VP2的基因先前已被引入允许宿主的细胞中。本发明中获得的蛋白VP2具有形成具有高免疫原性的空的嵌合衣壳的能力,因此它们可以被配制成用于保护动物免受CPV,FPLV和MEV引起的感染的疫苗。另外,它们可以被化学或遗传工程改造以掺入对应于其他病毒蛋白的表位,并且它们可以用于多价疫苗的制剂中。重组杆状病毒AcMNPV.pCPVEx17在使其能够形成伪病毒衣壳的条件下表达病毒CPV的蛋白VP2,并已保存在ECACC上。所述疫苗在兽医领域中得到应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号